Global Prostate Cancer Diagnosis and Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
Scope of the Report:
The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe.
The global Prostate Cancer Diagnosis and Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Diagnosis and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Prostate Cancer Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Diagnosis and Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Scope of the Report:
The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe.
The global Prostate Cancer Diagnosis and Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Diagnosis and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Prostate Cancer Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Diagnosis and Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Abbott Laboratories
- AbbVie
- Active Biotech
- Amgen
- Astellas Pharma
- AstraZeneca
- Bavarian Nordic
- Bayer
- Bristol-Myers Squibb
- Dendreon
- Endo
- Ferring Pharmaceuticals
- GE Healthcare
- GSK
- Ipsen
- Johnson & Johnson
- Pfizer
- Sanofi
- Siemens Healthineers
- Takeda
- Teva Pharmaceutical
- Tolmar Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Prostate specific antigen test (PSA)
- Digital rectal exam (DRE)
- Hospitals
- Diagnostic clinics
- Research centers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
1 PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment
1.2 Classification of Prostate Cancer Diagnosis and Treatment by Types
1.2.1 Global Prostate Cancer Diagnosis and Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Types in 2017
1.2.3 Prostate specific antigen test (PSA)
1.2.4 Digital rectal exam (DRE)
1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Global Prostate Cancer Diagnosis and Treatment Market by Regions
1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Prostate Cancer Diagnosis and Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Active Biotech
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bavarian Nordic
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bayer
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Dendreon
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Endo
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring Pharmaceuticals
2.12.1 Business Overview
2.12.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 GE Healthcare
2.13.1 Business Overview
2.13.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 GSK
2.14.1 Business Overview
2.14.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen
2.15.1 Business Overview
2.15.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Johnson & Johnson
2.16.1 Business Overview
2.16.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sanofi
2.18.1 Business Overview
2.18.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.19 Siemens Healthineers
2.19.1 Business Overview
2.19.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.20 Takeda
2.20.1 Business Overview
2.20.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.21 Teva Pharmaceutical
2.21.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.22 Tolmar Pharmaceuticals
2.22.1 Business Overview
2.22.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SIZE BY REGIONS
4.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
5.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
5.2 USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
6.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
6.2 Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.4 France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
7.2 China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.5 India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
8.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
8.2 Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE PROSTATE CANCER DIAGNOSIS AND TREATMENT BY COUNTRIES
9.1 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Type (2018-2023)
10.3 Prostate specific antigen test (PSA) Revenue Growth Rate (2013-2023)
10.4 Digital rectal exam (DRE) Revenue Growth Rate (2013-2023)
11 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2013-2018)
11.2 Prostate Cancer Diagnosis and Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic clinics Revenue Growth (2013-2018)
11.5 Research centers Revenue Growth (2013-2018)
12 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2018-2023)
12.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Regions (2018-2023)
12.3 North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.6 South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment
1.2 Classification of Prostate Cancer Diagnosis and Treatment by Types
1.2.1 Global Prostate Cancer Diagnosis and Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Types in 2017
1.2.3 Prostate specific antigen test (PSA)
1.2.4 Digital rectal exam (DRE)
1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Global Prostate Cancer Diagnosis and Treatment Market by Regions
1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Prostate Cancer Diagnosis and Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Active Biotech
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bavarian Nordic
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bayer
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Dendreon
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Endo
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring Pharmaceuticals
2.12.1 Business Overview
2.12.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 GE Healthcare
2.13.1 Business Overview
2.13.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 GSK
2.14.1 Business Overview
2.14.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen
2.15.1 Business Overview
2.15.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Johnson & Johnson
2.16.1 Business Overview
2.16.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sanofi
2.18.1 Business Overview
2.18.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.19 Siemens Healthineers
2.19.1 Business Overview
2.19.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.20 Takeda
2.20.1 Business Overview
2.20.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.21 Teva Pharmaceutical
2.21.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.22 Tolmar Pharmaceuticals
2.22.1 Business Overview
2.22.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SIZE BY REGIONS
4.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
5.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
5.2 USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
6.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
6.2 Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.4 France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
7.2 China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.5 India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA PROSTATE CANCER DIAGNOSIS AND TREATMENT REVENUE BY COUNTRIES
8.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
8.2 Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE PROSTATE CANCER DIAGNOSIS AND TREATMENT BY COUNTRIES
9.1 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Type (2018-2023)
10.3 Prostate specific antigen test (PSA) Revenue Growth Rate (2013-2023)
10.4 Digital rectal exam (DRE) Revenue Growth Rate (2013-2023)
11 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2013-2018)
11.2 Prostate Cancer Diagnosis and Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic clinics Revenue Growth (2013-2018)
11.5 Research centers Revenue Growth (2013-2018)
12 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2018-2023)
12.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Regions (2018-2023)
12.3 North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.6 South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Prostate Cancer Diagnosis and Treatment Picture
Table Product Specifications of Prostate Cancer Diagnosis and Treatment
Table Global Prostate Cancer Diagnosis and Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Types in 2017
Figure Prostate specific antigen test (PSA) Picture
Figure Digital rectal exam (DRE) Picture
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Application (2013-2023)
Figure Prostate Cancer Diagnosis and Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Diagnostic clinics Picture
Figure Research centers Picture
Table Global Market Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Prostate Cancer Diagnosis and Treatment Type and Applications
Table Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Prostate Cancer Diagnosis and Treatment Type and Applications
Table AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Active Biotech Basic Information, Manufacturing Base and Competitors
Table Active Biotech Prostate Cancer Diagnosis and Treatment Type and Applications
Table Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Prostate Cancer Diagnosis and Treatment Type and Applications
Table Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Prostate Cancer Diagnosis and Treatment Type and Applications
Table Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Prostate Cancer Diagnosis and Treatment Type and Applications
Table AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table Bavarian Nordic Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Dendreon Basic Information, Manufacturing Base and Competitors
Table Dendreon Prostate Cancer Diagnosis and Treatment Type and Applications
Table Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Endo Basic Information, Manufacturing Base and Competitors
Table Endo Prostate Cancer Diagnosis and Treatment Type and Applications
Table Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Type and Applications
Table Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Prostate Cancer Diagnosis and Treatment Type and Applications
Table GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Prostate Cancer Diagnosis and Treatment Type and Applications
Table GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Prostate Cancer Diagnosis and Treatment Type and Applications
Table Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prostate Cancer Diagnosis and Treatment Type and Applications
Table Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Prostate Cancer Diagnosis and Treatment Type and Applications
Table Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prostate Cancer Diagnosis and Treatment Type and Applications
Table Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table Siemens Healthineers Prostate Cancer Diagnosis and Treatment Type and Applications
Table Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Prostate Cancer Diagnosis and Treatment Type and Applications
Table Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Type and Applications
Table Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Tolmar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Type and Applications
Table Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2016
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2017
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions in 2017
Figure North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
Table North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
Table South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type in 2017
Table Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2018-2023)
Figure Global Prostate specific antigen test (PSA) Revenue Growth Rate (2013-2018)
Figure Global Digital rectal exam (DRE) Revenue Growth Rate (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue by Application (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application in 2017
Table Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Diagnostic clinics Revenue Growth Rate (2013-2018)
Figure Global Research centers Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Prostate Cancer Diagnosis and Treatment Picture
Table Product Specifications of Prostate Cancer Diagnosis and Treatment
Table Global Prostate Cancer Diagnosis and Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Types in 2017
Figure Prostate specific antigen test (PSA) Picture
Figure Digital rectal exam (DRE) Picture
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Application (2013-2023)
Figure Prostate Cancer Diagnosis and Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Diagnostic clinics Picture
Figure Research centers Picture
Table Global Market Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Prostate Cancer Diagnosis and Treatment Type and Applications
Table Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Prostate Cancer Diagnosis and Treatment Type and Applications
Table AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Active Biotech Basic Information, Manufacturing Base and Competitors
Table Active Biotech Prostate Cancer Diagnosis and Treatment Type and Applications
Table Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Prostate Cancer Diagnosis and Treatment Type and Applications
Table Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Prostate Cancer Diagnosis and Treatment Type and Applications
Table Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Prostate Cancer Diagnosis and Treatment Type and Applications
Table AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table Bavarian Nordic Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Type and Applications
Table Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Dendreon Basic Information, Manufacturing Base and Competitors
Table Dendreon Prostate Cancer Diagnosis and Treatment Type and Applications
Table Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Endo Basic Information, Manufacturing Base and Competitors
Table Endo Prostate Cancer Diagnosis and Treatment Type and Applications
Table Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Type and Applications
Table Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Prostate Cancer Diagnosis and Treatment Type and Applications
Table GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Prostate Cancer Diagnosis and Treatment Type and Applications
Table GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Prostate Cancer Diagnosis and Treatment Type and Applications
Table Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prostate Cancer Diagnosis and Treatment Type and Applications
Table Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Prostate Cancer Diagnosis and Treatment Type and Applications
Table Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prostate Cancer Diagnosis and Treatment Type and Applications
Table Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table Siemens Healthineers Prostate Cancer Diagnosis and Treatment Type and Applications
Table Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Prostate Cancer Diagnosis and Treatment Type and Applications
Table Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Type and Applications
Table Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Tolmar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Type and Applications
Table Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2016
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2017
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions in 2017
Figure North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
Table North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
Table South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type in 2017
Table Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2018-2023)
Figure Global Prostate specific antigen test (PSA) Revenue Growth Rate (2013-2018)
Figure Global Digital rectal exam (DRE) Revenue Growth Rate (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue by Application (2013-2018)
Table Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application in 2017
Table Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Diagnostic clinics Revenue Growth Rate (2013-2018)
Figure Global Research centers Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Prostate Cancer Diagnosis and Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
